Acquired Ichthyosis
Acquired ichthyosis (AI) is a disorder of skin keratinization that begins in adulthood in people with no inherited history of ichthyosis. Unlike the congenital forms, which are caused by gene mutations (FLG, STS), AI is not merely a cosmetic skin problem: it can be a paraneoplastic sign or a marker of serious internal disease. It shows up as gradually worsening dryness with small, diamond-shaped gray, brown or white scales that lift at the edges and overlap like fish scales, usually on the shins, forearms and trunk.
The underlying mechanism involves reduced production of surface lipids (cholesterol, ceramides), disturbed vitamin A metabolism, or excessive keratinocyte proliferation driven by cytokines, abnormal antibodies or metabolic toxins released by a tumor or systemic disease.
At Haute-Derma, diagnosing AI goes beyond treating dry skin on the surface. We focus on a structured systemic workup to uncover the hidden cause and keep our patients as safe as possible.
Underlying Causes and Conditions to Screen For
AI may be the first visible sign of a range of complex internal conditions:
- Malignancy (paraneoplastic disease):
- Hodgkin lymphoma: the most common cause of paraneoplastic AI. The scaling can appear months to years before the lymph nodes enlarge.
- Other blood cancers: non-Hodgkin lymphoma, multiple myeloma and leukemia.
- Solid tumors: lung, breast, ovarian and colorectal cancer.
- Autoimmune and systemic disease: systemic lupus erythematosus (SLE), sarcoidosis, dermatomyositis and systemic sclerosis.
- Metabolic and endocrine disorders: hypothyroidism, severe malnutrition, vitamin A or essential fatty acid deficiency, and chronic kidney disease.
- Chronic infections: HIV/AIDS, leprosy, and hepatitis B or C.
- Medications (drug-induced ichthyosis): long-term use of nicotinic acid (high-dose niacin), clofazimine, triparanol or allopurinol, or EGFR inhibitors used in targeted cancer therapy.
Congenital vs. Acquired Ichthyosis
| Feature | Congenital Ichthyosis | Acquired Ichthyosis (AI) |
|---|---|---|
| Onset | At birth, in infancy or in childhood | Adulthood or older age |
| Family history | Usually inherited (dominant, recessive or X-linked) | No family history |
| Root cause | Gene mutations (FLG, STS, ABCA12, etc.) | Malignancy, autoimmune, endocrine or infectious disease, medications |
| Associated conditions | Often part of multi-organ genetic syndromes | Hodgkin lymphoma, internal cancers, SLE, hypothyroidism |
| Course and outlook | Lifelong; stable or varies with the seasons | Depends on treating the underlying cause |
Diagnosis and Clinical Management at Haute-Derma
Dermoscopy and Skin Biopsy
- Digital dermoscopy: shows grayish-white, diamond-shaped scales with slightly lifting edges and shallow skin furrows, with none of the evenly distributed dotted vessels typical of psoriasis.
- Histopathology (when needed): retention hyperkeratosis with a basket-weave pattern, mild thinning of the spinous layer, and a reduced, absent or normal granular layer depending on how strongly the systemic cause affects the skin.
Invasive Resurfacing Is Strictly Contraindicated
- No strong chemical peels, microneedling or ablative laser: in AI the skin barrier is already badly damaged by lipid loss and broken cell-to-cell connections. Any chemical or invasive laser resurfacing can lead to ulceration, secondary infection and a Koebner-type reaction that spreads the lesions.
- Barrier repair and gentle keratolysis:
- Apply low-strength keratolytics (urea 5–10%, lactic acid 2–5% or salicylic acid 2%) in a rich moisturizer containing ceramides, cholesterol and free fatty acids in the standard 3:1:1 ratio.
- Bathe in lukewarm water and avoid harsh soaps; use gentle soap-free cleansers (syndets).
Systemic Screening and Referral
Patients with AI of unknown cause are offered an in-depth screening panel and referred to internal medicine or oncology:
- Complete blood count (CBC), erythrocyte sedimentation rate (ESR), CRP and urine protein.
- Thyroid function (FT3, FT4, TSH), plus liver and kidney function.
- Autoantibody panel (ANA, anti-dsDNA) and HIV antibody test.
- Chest X-ray, abdominal ultrasound, whole-body CT/PET-CT or GI endoscopy to look for a hidden cancer, especially lymphoma.
